Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01707524 · ClinicalTrials.gov registry record · NA

Left Versus Right Radial Artery and Radiation Exposure in Patients With Predictors of Trans-radial Failure

A NA study of Coronary Artery Disease, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT01707524 is a NA study of Coronary Artery Disease that has completed, run by NYU Langone Health. The registered enrollment target is 150 participants, below the 1,286-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01707524, a NA study of Coronary Artery Disease, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to measure radiation exposure during coronary angiography (CA) with a trans-radial approach (TRA), specifically comparing access via the left versus right radial artery in patients with suggested clinical predictors of TRA failure/difficult. These predictors include age \>70, female gender, height \<64 inches, and history of hypertension.The study also aims to determine difficulties encountered during left or right radial access in this specific patient population. A secondary aim is to compare the results of enrolled patients with a registry of patients where femoral access was obtained. Currently more than 1 million percutaneous coronary interventions (PCI) are performed in the United States annually. There is a growing trend to perform procedures utilizing the TRA due to recent data demonstrating decreased bleeding and access-site complications compared to the femoral approach. However, the TRA approach is also know to be associated with greater radiation exposure compared to the femoral approach. Furthermore, the TRA to catheterization may be difficult in certain populations because of anatomic considerations. Though traditionally completed via canalization of the right radial artery (RRA) due to feasibility with room setup, left radial artery (LRA) access may be superior due to the shorter distance needed to reach the ascending aorta and bypassing the tortuosity of the right subclavian artery. Given the benefits of the TRA, it is important to determine how left versus right radial artery access affects parameters of radiation exposure in addition to procedural difficulty. This study will be a prospective, randomized study of patients with suggested predictors of TRA failure/difficulty referred for coronary angiography. Patients referred for coronary angiography using the trans-radial approach will be randomly assigned to obtain arterial access via the right or left radial artery. A registry of patients referred for coronary angiograph

Conditions Studied

Interventions

  • PROCEDURE Randomized left versus right radial artery approach

Study Locations (1)

New York

  • New York University Langone Medical Center - New York

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2012-08
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT01707524

The ClinicalTrials.gov registry entry for NCT01707524 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,286-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (88% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which Randomized left versus right radial artery approach is the first listed.

NCT01707524 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT01707524 about?

NCT01707524 is a clinical study titled "Left Versus Right Radial Artery and Radiation Exposure in Patients With Predictors of Trans-radial Failure". The aim of this study is to measure radiation exposure during coronary angiography (CA) with a trans-radial approach (TRA), specifically comparing access via the left versus right radial artery in patients with suggested clinical predictors of TRA failure/difficult. These predictors include age \>70...

What is the current status of trial NCT01707524?

This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2012-08.

What conditions does trial NCT01707524 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

What interventions are being tested in trial NCT01707524?

The interventions under investigation include: Randomized left versus right radial artery approach (PROCEDURE).

Who is sponsoring clinical trial NCT01707524?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01707524 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.